We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for Pegzilarginase (AA-Med Pty Ltd)
Active ingredients
Pegzilarginase
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
solution for injection
Indication
Treatment of hyperargininaemia
Therapeutic area
Inherited metabolic disorders